Urticarial vasculitis successfully treated with omalizumab

Simple item page
dc.contributor.authorErmertcan A.T.
dc.contributor.authorAktas A.
dc.contributor.authorÖztürk F.
dc.contributor.authorTemiz P.
dc.date.accessioned2024-07-22T08:05:57Z
dc.date.available2024-07-22T08:05:57Z
dc.date.issued2021
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.12788/cutis.0272
dc.identifier.issn00114162
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13313
dc.language.isoEnglish
dc.publisherFrontline Medical Communications
dc.rightsAll Open Access; Bronze Open Access
dc.subjectHumans
dc.subjectOmalizumab
dc.subjectPeripheral Vascular Diseases
dc.subjectUrticaria
dc.subjectVasculitis
dc.subjectVasculitis, Leukocytoclastic, Cutaneous
dc.subjectomalizumab
dc.subjecthuman
dc.subjectleukocytoclastic vasculitis
dc.subjectperipheral vascular disease
dc.subjecturticaria
dc.subjectvasculitis
dc.titleUrticarial vasculitis successfully treated with omalizumab
dc.typeLetter

Files

Collections

Scopus Koleksiyonu